ROUNDTABLE HEALTHCARE PARTNERS MAKES INVESTMENT IN DEERLAND ENZYMES & PROBIOTICS

RoundTable Healthcare Partners (“RoundTable”), an operating-oriented private equity firm focused exclusively on the healthcare industry, announced today that it has made an investment in Deerland Enzymes & Probiotics (“Deerland” or the “Company”).

June 22, 2017

1 Min Read
Supply Side Supplement Journal logo in a gray background | Supply Side Supplement Journal

RoundTable Healthcare Partners (“RoundTable”), an operating-oriented private equity firm focused exclusively on the healthcare industry, announced today that it has made an investment in Deerland Enzymes & Probiotics (“Deerland” or the “Company”).

Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.

You May Also Like